SUBCUT HF II: a multicentre randomised controlled trial of SUBCUTaneous furosemide to support early discharge in patients admitted to hospital due to Heart Failure
9 May 2026 (08:00 - 12:45)
Organised by: 
About the speaker
University of Glasgow, Glasgow (United Kingdom of Great Britain & Northern Ireland)
9 More presentations in this session
Doctor I. Taraldsen (Copenhagen, DK)
Professor S. Rosenkranz (Cologne, DE)
Access the full session
The Event
Heart Failure 2026
9 May - 12 May 2026
You may be interested in
Congress Session
Congress Presentation
